Murine hepatocytes treated with EDPs in the context of nonalcoholic steatohepatitis linked to insulin resistance had decreased hepatic growth factor receptor (HGFR) phosphorylation as a consequence of NEU1-mediated HGFR desialylation (43). Here, MET is linked to metabolic dysfunction-associated steatohepatitis.